@article{20622,
  keywords = {Female, Humans, Male, Hydroxymethylglutaryl-CoA Reductase Inhibitors/ economics/ therapeutic use, Kidney Failure, Chronic/ drug therapy/ economics, Myocardial Infarction/ economics/ prevention & control, Pravastatin/ economics/ therapeutic use, Rhabdomyolysis, Stroke/ economics/ prevention & control},
  author = {Modi G. and Jha V.},
  title = {Cardiovascular disease: The price of a QALY--cost-effectiveness of statins in CKD},
  year = {2013},
  journal = {Nature Reviews Nephrology},
  volume = {9},
  edition = {2013/06/05},
  number = {7},
  pages = {377-9},
  isbn = {1759-507X (Electronic) - 1759-5061 (Linking)},
  note = {Jha, Vivekanand<br/>Modi, Gopesh K<br/>Comment<br/>England<br/>Nat Rev Nephrol. 2013 Jul;9(7):377-9. doi: 10.1038/nrneph.2013.104. Epub 2013 Jun 4.},
  language = {eng},
}